TGFB1 and neoplasm: First, the magnitude and isoform of TGF-β production by the tumor or its microenvironment is a critical parameter, and measuring circulating or biopsy-derived TGF-β isoform levels can guide treatment decisions regarding the optimal choice of the isoform-selectivity of a TGF-β ligand anti-antagonist.